(Q45065368)

English

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

van de Kerkhof PC

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

151

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

663-668

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical tria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

The Salford Psoriasis Index: an holistic measure of psoriasis severity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

Variations in population health status: results from a United Kingdom national questionnaire survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06134.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2004.06134.X

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45065368&oldid=2116919597"